Sophie* is a young girl who loves playing soccer, doodling in her sketchbook, and playing outside with her siblings. But after she turned seven years old, her and her mother started to notice signs of early puberty—body odor, breast buds, growth spurts, pubic hair, and even terrible acne.
Sophie and her mother visited her pediatrician to get an opinion on what Sophie was experiencing. Sophie’s symptoms led her pediatrician to believe that Sophie had central precocious puberty (CPP)—a condition that causes early puberty and height acceleration in children. They recommended Sophie and her mother consult with a pediatric endocrinologist to figure out how to treat Sophie’s condition. Left untreated, CPP could have negative life-long physical and mental consequences for Sophie.
Sophie was nervous, but the pediatric endocrinologist was incredibly encouraging and informative. They told Sophie how CPP is actually a more common condition than some think (1 in 5,000–10,000 girls experience CPP). They also explained she needs a treatment that blocks GnRH, which is the cause of early puberty.
While the pediatric endocrinologist mentioned several different treatment paths, Sophie’s mother had some preferences to help narrow down the options. First, Sophie needed a treatment for early puberty that didn’t require frequent visits to the doctor’s office so that she could maintain her active and athletic lifestyle. Enrollment for her treatment and visits should also be easy so that Sophie can stay focused on being a kid and her mom can easily navigate the process. Second, Sophie’s treatment ideally shouldn’t have any day-after muscle pain that often comes with injections into muscle. This muscle pain would not only hurt Sophie, but could impact her ability to play sports, dance or play with her friends. It goes without saying that mothers want their child to avoid as much pain as possible. (12, 13, 14)
With the preferences listed above, the treatment path revealed the choice that fulfilled these requests: Fensolvi. With Fensolvi, Sophie would only need to visit the doctor twice a year for a short needle injection. The drug slowly releases for six months to put a pause on puberty, letting Sophie enjoy her childhood.
With Fensolvi, Sophie plays soccer and enjoys her art projects as much as she did before her CPP symptoms started to show up in her life. And with Fensolvi’s easy enrollment plan, Sophie and her mother had an easier time getting her prescriptions and scheduling her biannual doctor visits.
If you like the sound of Sophie’s less invasive CPP treatment, you can learn more today by asking your healthcare provider about Fensolvi.
*Not an actual patient.